ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Clinical Cooperative Groups Funding To Decrease 42.5 Mil.

October 11, 1985

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

DCCR Free Up $5 Million; New Policy Limits Core Support

November 5, 1976

Eight Firms Join AACR As Sustaining Members

April 25, 1997

DRCA Planning Described; New Cancer Control Conference Set

February 4, 1983